These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1963179)

  • 1. Prevalence of antibodies to hepatitis C in different etiologies of cirrhosis.
    Dény P; Nicolas J; Loiseau D; Lefrère J
    J Hepatol; 1990 Nov; 11(3):393. PubMed ID: 1963179
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of anti-HCV antibodies in chronic liver disease in the Czech Republic.
    Stránský J; Horejsová M; Chlumská A; Honzáková E; Vandasová J; Nĕmecek V
    Infection; 1997; 25(1):49-50. PubMed ID: 9039541
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C core antibody detection in acute hepatitis and cirrhosis patients from Tunisia.
    Coursaget P; Simpson B; el Goulli N; Ben Khelifa H; Kastally R
    Pathol Biol (Paris); 1992 Jun; 40(6):646-8. PubMed ID: 1383914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver diseases.
    Ayoola EA; al-Mofleh IA; al-Faleh FZ; al-Rashed R; Arif MA; Ramia S; Mayet I
    Hepatogastroenterology; 1992 Aug; 39(4):337-9. PubMed ID: 1385286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiopathogenesis of chronic liver diseases detected and evaluated using immunologic tests].
    Baltă N; Constantinescu M; Popa-Mare A; Petec M; Dumitraşcu DL; Cernescu C
    Rev Roum Physiol (1990); 1992; 29(3-4):129-36. PubMed ID: 1284850
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural history of hepatitis C virus infection.
    Mondelli MU
    J Biol Regul Homeost Agents; 2003; 17(2):128-32. PubMed ID: 14518710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and significance of HCV infection in a consecutive series of patients with HBV antibodies and raised aminotransferases.
    Delle Monache M; Santolamazza M; Marinelli RM; Ricci GL
    Ital J Gastroenterol; 1991; 23(3):140-1. PubMed ID: 1660329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of regulatory T-cells during hepatitis C infection: From the acute phase to post-transplantation recurrence.
    Barjon C; Dahlqvist G; Calmus Y; Conti F
    Dig Liver Dis; 2015 Nov; 47(11):913-7. PubMed ID: 26216068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GOR-antibodies in patients with chronic liver disease and hepatocellular carcinoma.
    Rehermann B; Schneider A; Michel G; Braun HB; Manns MP
    Z Gastroenterol; 1994 Jul; 32(7):396-8. PubMed ID: 7975776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.
    Bruix J; Barrera JM; Calvet X; Ercilla G; Costa J; Sanchez-Tapias JM; Ventura M; Vall M; Bruguera M; Bru C
    Lancet; 1989 Oct; 2(8670):1004-6. PubMed ID: 2572739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HCV infection among cirrhotic patients as a risk factor for generation of hepatocellular carcinoma: preliminary report].
    Kobayashi S; Nagai Y; Nakao T; Nogami H; Isono K
    Nihon Geka Gakkai Zasshi; 1991 Nov; 92(11):1666. PubMed ID: 1722866
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenprocoumon-induced hepatitis mimicking non-A, non-B hepatitis.
    de Man RA; Wilson JH; Schalm SW; ten Kate FJ; van Leer E
    J Hepatol; 1990 Nov; 11(3):318-21. PubMed ID: 1963177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus-associated glomerulonephritis.
    Stehman-Breen C; Johnson RJ
    Adv Intern Med; 1998; 43():79-97. PubMed ID: 9506179
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of humoral antigenic determinants in the hepatitis C virus NS3 protein.
    Hwang LH; Yang PM; Lai MY; Chiang BL; Kao JH; Wang JT; Lee SY; Chian HM; Chi WK; Chu YD; Chen PJ; Chen DS
    J Infect Dis; 1996 Jul; 174(1):173-6. PubMed ID: 8655988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of the C virus in the chronicity of viral hepatitis].
    Claici C; Nicoară E; Roşiu N; Strain R; Vâlculescu C; Chidiosan CM; Nicolescu I; Cioflec D; Claici D; Don E
    Bacteriol Virusol Parazitol Epidemiol; 1994; 39(1-2):70-2. PubMed ID: 7981531
    [No Abstract]   [Full Text] [Related]  

  • 16. Innate immunity against hepatitis C virus.
    Xu Y; Zhong J
    Curr Opin Immunol; 2016 Oct; 42():98-104. PubMed ID: 27366996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk of hepatitis C in health personnel].
    Magnavita N
    Med Lav; 2002; 93(4):347-8. PubMed ID: 12212404
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients.
    Espinosa M; Martin-Malo A; Alvarez de Lara MA; Aljama P
    Nephrol Dial Transplant; 2001 Aug; 16(8):1669-74. PubMed ID: 11477172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GB virus type C cross-reactivity in clinical samples with a low hepatitis C virus antibody positive response.
    Lapa D; Agrati C; Scognamiglio P; Cimini E; Capobianchi MR; Garbuglia AR
    APMIS; 2019 Feb; 127(2):109-111. PubMed ID: 30698305
    [No Abstract]   [Full Text] [Related]  

  • 20. Sexual transmission of hepatitis C virus.
    Vranckx R
    BMJ; 1991 Sep; 303(6805):783. PubMed ID: 1657258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.